ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,013.13
-1.71%
US Tech 100
21,039.16
-2.09%
다우존스 지수
43,428.02
-1.69%
Bitcoin
95,379.07
-0.93%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Arcutis Biotherapeutics Inc (ARQT) 시세

Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics Inc (ARQT)

NASDAQ
13.02
-0.40
(-2.98%)
마감 24 2월 6:00AM
15분 지연
13.02
0.01
(0.08%)
시간외 거래: 9:23AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
13.02
매수가
12.97
매도가
13.32
거래량
1,886,972
12.75 일간 변동폭 13.94
6.99 52주 범위 16.20
market_cap
1.524B
전일 종가
13.42
개장가
13.62
최근 거래 시간
50
@
13.22
마지막 거래 시간
재정 규모
US$ 24,837,977
VWAP
13.1629
평균 볼륨(3m)
2,112,960
발행 주식
117,044,591
배당수익률
-
주가수익률
-5.81
주당순이익(EPS)
-2.24
매출
59.61M
순이익
-262.14M

Arcutis Biotherapeutics Inc 정보

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targe... Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate, roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.arcutis.com
본부
Wilmington, Delaware, USA
설립됨
-
Arcutis Biotherapeutics Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker ARQT. The last closing price for Arcutis Biotherapeutics was US$13.42. Over the last year, Arcutis Biotherapeutics shares have traded in a share price range of US$ 6.99 to US$ 16.20.

Arcutis Biotherapeutics currently has 117,044,591 shares in issue. The market capitalisation of Arcutis Biotherapeutics is US$1.57 billion. Arcutis Biotherapeutics has a price to earnings ratio (PE ratio) of -5.81.

Arcutis Biotherapeutics (ARQT) 옵션 플로우 요약

전체 옵션 플로우 보기

전체 흐름

강세

순 프리미엄

64k

Calls / Puts

100.00%

매수 / 매도

100.00%

OTM / ITM

0.00%

Sweeps 비율

0.00%

ARQT 최신 뉴스

추가 뉴스

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 2월 2025
ARQT (-2.98%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 2월 2025
ARQT (-2.98%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 2월 2025
ARQT (-2.98%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 2월 2025
ARQT (-2.98%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
04 2월 2025
ARQT (-2.98%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
04 2월 2025
ARQT (-2.98%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
04 2월 2025
ARQT (-2.98%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.423.3333333333312.613.7412.19167783012.92701635CS
4-0.48-3.5555555555613.515.0911.13227793412.91398226CS
121.2110.245554614711.8116.211.13211296013.46903092CS
264.5453.53773584918.4816.28.03204367711.48310782CS
523.6238.51063829799.416.26.99262123710.36427772CS
156-2.77-17.54274857515.7927.41.7619245539.1288486CS
260-13.86-51.562526.8840.881.76122106410.20363632CS

ARQT - Frequently Asked Questions (FAQ)

What is the current Arcutis Biotherapeutics share price?
The current share price of Arcutis Biotherapeutics is US$ 13.02
How many Arcutis Biotherapeutics shares are in issue?
Arcutis Biotherapeutics has 117,044,591 shares in issue
What is the market cap of Arcutis Biotherapeutics?
The market capitalisation of Arcutis Biotherapeutics is USD 1.57B
What is the 1 year trading range for Arcutis Biotherapeutics share price?
Arcutis Biotherapeutics has traded in the range of US$ 6.99 to US$ 16.20 during the past year
What is the PE ratio of Arcutis Biotherapeutics?
The price to earnings ratio of Arcutis Biotherapeutics is -5.81
What is the cash to sales ratio of Arcutis Biotherapeutics?
The cash to sales ratio of Arcutis Biotherapeutics is 25.54
What is the reporting currency for Arcutis Biotherapeutics?
Arcutis Biotherapeutics reports financial results in USD
What is the latest annual turnover for Arcutis Biotherapeutics?
The latest annual turnover of Arcutis Biotherapeutics is USD 59.61M
What is the latest annual profit for Arcutis Biotherapeutics?
The latest annual profit of Arcutis Biotherapeutics is USD -262.14M
What is the registered address of Arcutis Biotherapeutics?
The registered address for Arcutis Biotherapeutics is 3411 SILVERSIDE ROAD TATNALL, BUILDING #104, NEW CASTLE, WILMINGTON, DELAWARE, 19810
What is the Arcutis Biotherapeutics website address?
The website address for Arcutis Biotherapeutics is www.arcutis.com
Which industry sector does Arcutis Biotherapeutics operate in?
Arcutis Biotherapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MLGOMicroAlgo Inc
US$ 6.3767
(454.50%)
531.54M
BOXLBoxlight Corporation
US$ 3.1099
(51.70%)
1.84M
GDEVGDEV Inc
US$ 20.90
(46.56%)
264.44k
IVVDInvivyd Inc
US$ 1.7501
(44.64%)
37.75M
UPCUniverse Pharmaceuticals Inc
US$ 0.2003
(40.56%)
420.21M
DOYUDouYu International Holdings Ltd
US$ 7.19
(-55.31%)
1.28M
MNDRMobile health Network Solutions
US$ 0.5048
(-46.29%)
18.61M
BLUEbluebird bio Inc
US$ 4.09
(-41.90%)
5.44M
FLDFold Holdings Inc
US$ 6.95
(-37.39%)
488.54k
GCLGCL Global Holdings Ltd
US$ 3.83
(-31.48%)
635.26k
MLGOMicroAlgo Inc
US$ 6.3767
(454.50%)
531.54M
UPCUniverse Pharmaceuticals Inc
US$ 0.2003
(40.56%)
420.21M
ADTXAditxt Inc
US$ 0.0922
(-22.39%)
278.25M
NVDANVIDIA Corporation
US$ 134.43
(-4.05%)
228.14M
HOLOMicroCloud Hologram Inc
US$ 1.565
(31.51%)
190.81M

ARQT Discussion

게시물 보기
52172 52172 2 월 전
Keep marching 20's imminent 
👍️0
Monksdream Monksdream 6 월 전
ARQT under $15
👍️0
52172 52172 6 월 전
Ath’s incoming
👍️0
52172 52172 6 월 전
Put the crackpipe down
👍️0
52172 52172 6 월 전
Wrong we beat big time sucka
👍️0
52172 52172 6 월 전
12 coming
👍️0
Sierra20 Sierra20 6 월 전
$6 coming
👍️0
Sierra20 Sierra20 6 월 전
Earnings missed big time and this tanks hard
👍️0
52172 52172 7 월 전
Not yet need 20’s which will come
👍️ 1
MiamiGent MiamiGent 7 월 전
ARQT $10.82 HOD!
Everybody happy?
👍️0
52172 52172 7 월 전
Some large transactions happening a sign of whats to come
👍️ 1
52172 52172 8 월 전
Gonna close green watch
👍️0
MiamiGent MiamiGent 8 월 전
ARQT The short interest is about 25%
The free trading float is tiny.
Share Price should rise steadily today.
👍️0
MiamiGent MiamiGent 8 월 전
ARQT $10.69 last pre-mkt buy, up .67 from yesterday's close.
Steadily rising, as I expected.

The mkt for this FDA approved medicine (last night) is reportedly multi- billions of dollars.
👍️0
52172 52172 8 월 전
Im hoping!
👍️0
MiamiGent MiamiGent 8 월 전
ARQT Needham Reiterates BUY on Arcutis Biotherapeutics, maintains $18 Price Target

6:28 AM this morning
👍️0
MiamiGent MiamiGent 8 월 전
ARQT That's right. The market for this is reportedly three times larger than the previous approved candidate- and that one grew about 250% last qtr.
AND, Arcutis (ARQT) will roll out this new medicine by the end of THIS MONTH.

I am going to buy this product- I have psoriasis all over, except my face thank God.
👍️0
52172 52172 8 월 전
Real revenue is gonna begin to come in.
👍️0
52172 52172 8 월 전
Headed to 20’s soon enough!
👍️0
MiamiGent MiamiGent 8 월 전
$ARQT HUge short interest, next to no free float and FDA Approval tonight for a BIG MARKET drug.
The boys will run this tomorrow.
👍️0
MiamiGent MiamiGent 8 월 전
$ARQT
Arcutis Biotherapeutics Inc

My guess it'll be $11 by 8PM.
The real fun starts in Pre-Market, tomorrow, And then I think off to the races in Regular Session.
Bullish
👍️0
MiamiGent MiamiGent 8 월 전
$ARQT Tight Bid and ASK now.
Getting serious.
Bid ARCX
10.55 x 10
Ask XNMS
10.59 x 1
Volume
2,437,578
Bullish
👍️0
MiamiGent MiamiGent 8 월 전
$ARQT
Arcutis Biotherapeutics Inc

I told ya!
Currently in AH
Bid XNMS 10.50 x 13
Ask ARCX 10.67 x 20
Volume
2,429,849
Bullish
👍️0
MiamiGent MiamiGent 8 월 전
$ARQT New traders: Look at those big $10.48 buys!
The few that follow are "paint jobs"- shorts trying to paint weakness.
Pay attention to the big buys!
$ARQT
18:07:49 $10.41 5 paint job
18:07:49 $10.35 20 paint job
18:07:45 $10.48 15 paint job
18:07:25 $10.48 7,900 real buy
18:07:25 $10.48 1,500 real buy
18:07:01 $10.3567 30
18:05:44 $10.49 115
18:04:57 $10.49 9,400
18:04:26 $10.4887 110
18:03:38 $10.42 6,212
18:03:38 $10.42 2,200
Bullish
👍️0
MiamiGent MiamiGent 8 월 전
ARQT Arcutis Biotherapeutics' Zoryve Gets US FDA Approval!
👍️0
Sierra20 Sierra20 8 월 전
I hope it will be approved. I think it will be approved. It’s just weird.
👍️0
MiamiGent MiamiGent 8 월 전
You're being unnecessarily doomsdayish, Sierra.

Fact is FDA has not announced re any candidates since July 3rd. There's an American holiday on the 4th (Thursday) and folks often take the next day off to make it a four-day break with only one vacation day used.
Hope the weather is not as hot in Albania or wherever it is you plot your short plays and bashing.
MG
👍️0
Sierra20 Sierra20 8 월 전
CRL more than likely. I knew it. F! This is horrible!!!!
https://investors.arcutis.com/news-releases/news-release-details/arcutis-provides-update-snda-roflumilast-cream-015-atopic/
👍️0
Sierra20 Sierra20 8 월 전
They got CRL. 😔
There’s no other reason for this delay. Back to $5 I think.
👍️0
Sierra20 Sierra20 8 월 전
I think they are talking to fda to figure out what they needed to do to address the fda’s concerns before giving a pr about CRL.
👍️0
MiamiGent MiamiGent 8 월 전
ARQT Only 40 more minutes for FDA to announce today.
One time it did at 11:30 PM and it was a QUADRUPLE!
👍️0
MiamiGent MiamiGent 8 월 전
You must be short. There's no basis for what you are saying.
👍️0
MiamiGent MiamiGent 8 월 전
AQRT I'm in today.
👍️0
Sierra20 Sierra20 8 월 전
CRL coming at 4 pm est. imo.
👍️0
Sierra20 Sierra20 8 월 전
I think CRL coming…
👍️0
Sierra20 Sierra20 8 월 전
Run
👍️0
52172 52172 8 월 전
Havent missed nothing yet!
👍️0
52172 52172 8 월 전
Monday boom!
👍️0
Sierra20 Sierra20 8 월 전
I have the worst luck. I miss all the PDUFA. If they get delayed should not be a problem.
👍️0
Sierra20 Sierra20 8 월 전
Oh no!!!!!
👍️0
Sierra20 Sierra20 8 월 전
CRL? Delayed? What’s going on?
👍️0
Monksdream Monksdream 8 월 전
ARQT under$10
👍️0
52172 52172 8 월 전
No one knows shit approval is imminent
👍️0
Sierra20 Sierra20 8 월 전
Someone knows something sell off started. 😔
👍️0
Sierra20 Sierra20 8 월 전
I hope they didn’t get a CRL. People are selling. Something is going on.
👍️0
52172 52172 8 월 전
408k share buy ah’s nothing else needed to say!
👍️0
52172 52172 8 월 전
20’s imminent mark this post
👍️0
52172 52172 9 월 전
Load the boat easy money
👍️0
52172 52172 9 월 전
Buy opp!
👍️0
52172 52172 10 월 전
ER coming on the 14th might get a bump then data in july
👍️0

최근 히스토리

NASDAQ
ARQT
Arcutis Biotherapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지